Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period - Concepedia

Concepedia

Publication | Open Access

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

DOI Full Paper Access

153

Citations

18

References

2019

Year

Anthony A. Portale, Thomas O. Carpenter, Maria Luisa Brandi, Karine Briot, Hae II Cheong, Martine Cohen‐Solal, Rachel Crowley, Suzanne M. Jan de Beur, Richard Eastell, Yasuo Imanishi,

Calcified Tissue International

References

	Year	Citations

Page 1